Vident Investment Advisory’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,680
Closed -$277K 1315
2023
Q1
$277K Buy
5,680
+1,363
+32% +$69.4K 0.01% 981
2022
Q4
$228K Buy
+4,317
New +$213K 0.01% 985
2022
Q1
Sell
-3,835
Closed -$226K 1333
2021
Q4
$226K Sell
3,835
-530
-12% -$30.4K 0.01% 1106
2021
Q3
$239K Buy
4,365
+157
+4% +$8.74K 0.01% 1048
2021
Q2
$216K Sell
4,208
-29,431
-87% -$1.52M 0.01% 1026
2021
Q1
$1.74M Sell
33,639
-14,823
-31% -$814K 0.06% 428
2020
Q4
$2.72M Buy
48,462
+22,420
+86% +$1.2M 0.11% 174
2020
Q3
$1.44M Buy
26,042
+3,243
+14% +$168K 0.07% 383
2020
Q2
$1.03M Buy
+22,799
New +$1.02M 0.05% 466
2020
Q1
Sell
-273,561
Closed -$9.8M 843
2019
Q4
$9.8M Sell
273,561
-54,431
-17% -$2.02M 0.61% 42
2019
Q3
$11.5M Buy
327,992
+8,489
+3% +$327K 1% 36
2019
Q2
$13.7M Sell
319,503
-6,964
-2% -$289K 1.11% 27
2019
Q1
$14.1M Sell
326,467
-11,926
-4% -$480K 0.76% 19
2018
Q4
$12.4M Sell
338,393
-155,834
-32% -$5.79M 0.69% 29
2018
Q3
$19.9M Sell
494,227
-86,641
-15% -$3.46M 0.78% 34
2018
Q2
$22.3M Sell
580,868
-67,502
-10% -$2.48M 0.88% 21
2018
Q1
$22.5M Buy
648,370
+88,668
+16% +$3.11M 0.91% 26
2017
Q4
$18.4M Buy
559,702
+196,561
+54% +$6.77M 0.83% 32
2017
Q3
$12.1M Buy
363,141
+149,658
+70% +$5.16M 0.66% 39
2017
Q2
$7.59M Buy
213,483
+82,988
+64% +$2.8M 0.63% 34
2017
Q1
$4.01M Buy
+130,495
New +$4.02M 0.4% 54

Other funds holding QGEN

Vident Investment Advisory's QGEN Position: Q2 2023 in Review

Vident Investment Advisory sold out of Qiagen (QGEN) in Q2 2023, closing a stake of 5,680 shares — an estimated $277K sold.

Vident Investment Advisory first reported a position in QGEN in Q1 2017 and held it in 21 quarters. The position peaked at $22.5M in Q1 2018. 282 funds tracked by Wall St. Rank hold QGEN as of Q2 2023.

  • Vident Investment Advisory reported no remaining Qiagen position as of Q2 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 5,680 Qiagen shares in Q2 2023, an estimated $277K.
  • Vident Investment Advisory first reported a position in Qiagen in Q1 2017 and held it in 21 quarters.
  • Vident Investment Advisory's Qiagen position peaked at $22.5M in Q1 2018.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.